Literature DB >> 23098053

Colonization by Candida species of the oral and vaginal mucosa in HIV-infected and noninfected women.

Daniel Merenstein1, Haihong Hu, Cuiwei Wang, Pilar Hamilton, Mandy Blackmon, Hui Chen, Richard Calderone, Dongmei Li.   

Abstract

Candidiasis in HIV/AIDS patients continues to be a public health problem. Effective antifungal therapies are few in number and have inherent problems such as selecting for drug-resistant strains of Candida species. To evaluate the state of Candida colonization of the oral and vaginal mucosa, we recruited 80 women, both HIV-infected and HIV-uninfected, from the Women's Interagency HIV Study (WIHS). Diet diaries were collected by participants to examine the role of diet on fungal growth. Baseline studies were initially done in participants that followed the colonization of both mucosal sites over 0-90 days. The most common Candida species from both groups of patients were C. albicans and C. glabrata. Among the HIV-infected cohort, the percentage of participants who were positive for Candida spp. was higher than in the HIV-uninfected control group. Furthermore, the frequency of colonization (1 episode versus >1 episode) was also increased in the HIV-infected cohort. These data indicate that Candida species remain an important component of the microbial community in both populations.

Entities:  

Mesh:

Year:  2012        PMID: 23098053      PMCID: PMC3537294          DOI: 10.1089/AID.2012.0269

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  18 in total

1.  Survival in experimental Candida albicans infections depends on inoculum growth conditions as well as animal host.

Authors:  F C Odds; L Van Nuffel; N A Gow
Journal:  Microbiology       Date:  2000-08       Impact factor: 2.777

Review 2.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

3.  Prevalence, incidence, and recurrence of oral lesions among HIV-infected patients on HAART in Alabama: a two-year longitudinal study.

Authors:  Irene M Tamí-Maury; James H Willig; Pauline E Jolly; Sten Vermund; Inmaculada Aban; Jeffery D Hill; Craig M Wilson; Mirjam-Collette Kempf
Journal:  South Med J       Date:  2011-08       Impact factor: 0.954

Review 4.  Probiotics: do they have a role in oral medicine and dentistry?

Authors:  Jukka H Meurman
Journal:  Eur J Oral Sci       Date:  2005-06       Impact factor: 2.612

5.  The Women's Interagency HIV Study. WIHS Collaborative Study Group.

Authors:  S E Barkan; S L Melnick; S Preston-Martin; K Weber; L A Kalish; P Miotti; M Young; R Greenblatt; H Sacks; J Feldman
Journal:  Epidemiology       Date:  1998-03       Impact factor: 4.822

Review 6.  Distinct protective host defenses against oral and vaginal candidiasis.

Authors:  Paul L Fidel
Journal:  Med Mycol       Date:  2002-08       Impact factor: 4.076

7.  Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis.

Authors:  Jack D Sobel; Harold C Wiesenfeld; Mark Martens; Penny Danna; Thomas M Hooton; Anne Rompalo; Malcolm Sperling; Charles Livengood; Benson Horowitz; James Von Thron; Libby Edwards; Helene Panzer; Teng-Chiao Chu
Journal:  N Engl J Med       Date:  2004-08-26       Impact factor: 91.245

Review 8.  Oral opportunistic infections in HIV-positive individuals: review and role of mucosal immunity.

Authors:  Janet E Leigh; Kishore Shetty; Paul L Fidel
Journal:  AIDS Patient Care STDS       Date:  2004-08       Impact factor: 5.078

9.  Growth kinetics and morphology of colonies of the filamentous form of Candida albicans.

Authors:  N A Gow; G W Gooday
Journal:  J Gen Microbiol       Date:  1982-09

Review 10.  Treatment of vaginal Candida infections.

Authors:  Jack D Sobel
Journal:  Expert Opin Pharmacother       Date:  2002-08       Impact factor: 3.889

View more
  19 in total

1.  The mycobiota of the human body: a spark can start a prairie fire.

Authors:  Di Zhang; Ying Wang; Sunan Shen; Yayi Hou; Yugen Chen; Tingting Wang
Journal:  Gut Microbes       Date:  2020-03-09

Review 2.  Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans.

Authors:  Andrew T Nishimoto; Cheshta Sharma; P David Rogers
Journal:  J Antimicrob Chemother       Date:  2020-02-01       Impact factor: 5.790

Review 3.  Candida albicans cell-type switching and functional plasticity in the mammalian host.

Authors:  Suzanne M Noble; Brittany A Gianetti; Jessica N Witchley
Journal:  Nat Rev Microbiol       Date:  2016-11-21       Impact factor: 60.633

Review 4.  Fungal dysbiosis: immunity and interactions at mucosal barriers.

Authors:  Iliyan D Iliev; Irina Leonardi
Journal:  Nat Rev Immunol       Date:  2017-06-12       Impact factor: 53.106

5.  Combination of Estrogen and Immunosuppressive Agents to Establish a Mouse Model of Candidiasis with Concurrent Oral and Vaginal Mucosal Infection.

Authors:  Le Wang; Chong Wang; Huan Mei; Yongnian Shen; Guixia Lv; Rong Zeng; Ping Zhan; Dongmei Li; Weida Liu
Journal:  Mycopathologia       Date:  2015-09-24       Impact factor: 2.574

6.  Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques.

Authors:  Luca Micci; Emily S Ryan; Rémi Fromentin; Steven E Bosinger; Justin L Harper; Tianyu He; Sara Paganini; Kirk A Easley; Ann Chahroudi; Clarisse Benne; Sanjeev Gumber; Colleen S McGary; Kenneth A Rogers; Claire Deleage; Carissa Lucero; Siddappa N Byrareddy; Cristian Apetrei; Jacob D Estes; Jeffrey D Lifson; Michael Piatak; Nicolas Chomont; Francois Villinger; Guido Silvestri; Jason M Brenchley; Mirko Paiardini
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

7.  HIV infection as a risk factor for vaginal dysbiosis, bacterial vaginosis, and candidosis in pregnancy: A matched case-control study.

Authors:  Philipp Foessleitner; Ljubomir Petricevic; Isabell Boerger; Irene Steiner; Herbert Kiss; Armin Rieger; Veronique Touzeau-Roemer; Alex Farr
Journal:  Birth       Date:  2021-01-18       Impact factor: 3.689

8.  Effect of highly active antiretroviral therapy on vaginal Candida spp. isolation in HIV-infected compared to HIV-uninfected women.

Authors:  Silvia de Souza Dantas Alczuk; Patrícia de Souza Bonfim-Mendonça; Sheila Cristina Rocha-Brischiliari; Cristiane Suemi Shinobu-Mesquita; Helen Priscilla Rodrigues Martins; Fabrícia Gimenes; André Luelsdorf Pimenta de Abreu; Maria Dalva de Barros Carvalho; Sandra Marisa Pelloso; Terezinha Inez Estivalet Svidzinski; Marcia Edilaine Lopes Consolaro
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Mar-Apr       Impact factor: 1.846

9.  Estrogen treatment predisposes to severe and persistent vaginal candidiasis in diabetic mice.

Authors:  Mawieh Hamad
Journal:  J Diabetes Metab Disord       Date:  2014-01-08

Review 10.  Systems Level Dissection of Candida Recognition by Dectins: A Matter of Fungal Morphology and Site of Infection.

Authors:  Lisa Rizzetto; Tobias Weil; Duccio Cavalieri
Journal:  Pathogens       Date:  2015-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.